Member Info for 28jaczar01

Looks like this stock is quietly getting bought up as the share price ticks up nicely in recent days, so I am in for a tranche this morning.

£8 million mcap with 1/2 that on the book as cash. Low number of shares available and they were a dividend payer pre-Covid which should hopefully return this year.

The importance of IT services including blockchain grows ever more important as the pandemic accelerates the world towards digitisation, which should support Triad’s growth and profitability.

wondering about these 1 million share sells just landing this morning......is someone offloading placing shares for a nice 50+% profit in 6 weeks ? Could explain the recent Twitter noise (Tops etc) How many more to sell I wonder.....be careful buyers

Thanks for reply.

Beforehand I had thought that OBC involvement here was primarily with the development and maintenance of the related blockchain software for users of Brazio, plus one coin etc.......thus providing them with related licensing fees as their revenue stream.

I had not previously considered that OBC were actively mining and Hodling these crypto in significant quantity themselves as part of their revenue stream strategy and therefore benefitting strongly from these recent prices / market cap increases (similar to argo doing with BTC/zcash)

Based on this new understanding, I will look to take a tranche of these tomorrow morning.

It’s good news for the Brazio price increase but needs to be taken in the context that the entire market cap as per the provided link is only at 100,000 USD.......it ain’t Bitcoin.......

Wow —- the most positive BTC crypto news report I have seen on MSM..... ;)

Bitcoin at record price getting coverage on sky breakfast news right now......snowballing.....

Fully agree with where your coming from.....

Arb are mining a supply limited commodity (BTC) where the customer demand for it grows insatiably by the day....nae by the hour.....

Whilst BTC has currently increased from 29,000 to 34,000 (+17.3%) just since LSE closed on NYE, the profit margin for Argo mining if you conservatively take 10,000 as their all in costs (including depreciation etc) has increased more significantly by +26.3%.

That surely puts tomorrow SP for Argo into the 40s without even accounting for the potential of where this is quickly heading....

I don’t think people have long to get on board before this is up at £1+

It was at pretty much bang on 29,000 USD.......

Perhaps that 85 PH of capacity that was taken offline back in October when BTC was at a much lower price was able to be brought back online during December period if the significantly increasing BTC price meant this previously lost capacity could now deliver a positive contribution to Argo’s overall performance.

Wouldn’t that be a nice piece of news to see as part of the December monthly update RNS that’s due for publication this coming week......

Interesting that the large 8,555,000 trade this morning comes to 2.9% of total shares........someone wants to keep their cards close to their chest here by staying just under the 3% TR1 notification limit........

Appreciate your reply 13thmonkey, however based on the MicrotoxBT video demonstration published on 24th Sept 2020 there appears to be more complexity involved to the breathalyser device operation in relation to the direct interaction with the user’s mouth than simply placing the mouth piece into the mouth and giving a breath. What we see on the video is a saline mist being passed from the device into the user’s mouth as a part of the breath sampling process.

Let’s see if Gerry can provide the necessary insight when he spots this post subject.

Thx

I am a new LSE poster who is a medium term (pre COVID) investor in both DVRG (SKIN as was) and AVACTA and I believe strongly in both Companies future potential.

I was this morning reading again thru the large number of presentation Q&A from the AVACTA interim results ended 30th June 2020 and I came to number 34 as follows:

QUESTION: “LFT - collection tube & pipette required - any scope for users simply placing the test in their mouths?”
ANSWER: “If the test was placed in the user’s mouth then that would create very considerable additional regulatory complexities and hurdles. The device would have to be manufactured and packaged under aseptic conditions which would significantly impact manufacturing capacity and cost, which would make this a highly undesirable approach”

Whilst this Q&A related specifically to the COVID-19 LFT that AVACTA is implementing, it got me concerned for the likewise relevance of this matter for DVRG’s microtoxBT which involves placing into the user’s mouth for providing the breath sample.....

Perhaps the recent bringing on board to the collaboration of PulmoBioMed Ltd is going to help with suitably addressing this aspect for the microtoxBT if it is relevant ?

I would really appreciate feedback from Gerry + any other diagnostics equipment knowledgable posters on this board who can hopefully take away my current concern on this matter with respect to the MicrotoxBT as to whether it is relevant and if it is, that it is being timely taken into account as part of the ongoing development / implementation of the MicrotoxBT.

Thx